Minerva Neurosciences to Participate in The Citizens Life Sciences Conference
Minerva Neurosciences (Nasdaq: NERV) announced that Remy Luthringer, PhD, Executive Chairman & Chief Executive Officer, will present at The Citizens Life Sciences Conference in Miami on March 10-11, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Minerva Neurosciences (Nasdaq: NERV) announced that Remy Luthringer, PhD, Executive Chairman & Chief Executive Officer, will present at The Citizens Life Sciences Conference in Miami on March 10-11, 2026.
The company will deliver a company presentation on Tuesday, March 10 at 9:35 AM ET; a live webcast and a replay available for ninety days will be provided, according to the company.
Details
News Market Reaction – NERV
On Mar 4, the day this news came out, NERV closed 0.44% below the previous close.
Data tracked by StockTitan Argus for the Mar 4 session.
Key Figures
- Conference dates
- March 10–11, 2026
- The Citizens Life Sciences Conference in Miami, FL
- Presentation time
- 9:35 AM ET
- Company presentation on Tuesday, March 10, 2026
- Replay availability
- 90 days
- Webcast replay on Investors & Media Events webpage
Historical Context
-
Announced virtual KOL event on roluperidone and planned 2026 Phase 3 trial.
-
Appointed new director and highlighted private placement up to $200 million.
-
Reported Q3 2025 results and detailed $80M upfront plus additional warrant funding.
-
Announced financing of up to $200M to fund Phase 3, NDA resubmission, launch prep.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BURLINGTON, Mass., March 04, 2026 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today announced that Remy Luthringer, PhD, Executive Chairman & Chief Executive Officer, will participate in The Citizens Life Sciences Conference being held March 10-11, 2026 in Miami, FL.
| The Citizens Life Sciences Conference | |
| Format: | Company presentation |
| Day/Time: | Tuesday, March 10 at 9:35 AM ET |
| Webcast: | https://event.summitcast.com/view/BuMiPNPtyHKimMF6k4AFMd/SKrutqyvQVtnaKJDseE6uU |
If you are interested in meeting with the Minerva team during the conference, please reach out to your Citizens Bank representative.
A replay of the presentation will be available on the Company's Investors & Media Events and Presentations webpage for ninety days following the event.
About Minerva Neurosciences
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing product candidates to treat CNS diseases. Minerva is initiating a confirmatory Phase 3 trial with roluperidone for negative symptoms of schizophrenia. For more information, please visit the Company’s website.
Contacts:
Investor inquiries:
Frederick Ahlholm
Chief Financial Officer
Minerva Neurosciences, Inc.
FAhlholm@minervaneurosciences.com
Corey Davis, Ph.D.
LifeSci Advisors, LLC
212-915-2577
cdavis@lifesciadvisors.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.